Funding Search - Pivot

The University of Vermont, through Sponsored Project Administration (SPA) subscribes to Pivot, a web-based funding search tool. The UVM Cancer Center has collaborated with SPA to create a customized cancer relevant pivot search. Press the button for Cancer Funding Opportunities.

Cancer Funding Opportunities

If you would prefer to set up your own pivot search and automated alerts you can learn more about pivot HERE.

For Pivot Assistance

Please review the information provided by SPA

Hilda Alajajian, Grant Resources Specialist is available to meet with individuals or groups for assistance in identifying funding

Phone: (802)656-1322

Should you learn of an opportunity not listed here but important to UVM Cancer Center research, please contact Laura Gordon.


Peer-Reviewed Funding Sources

Below is a list of fund sources from federal agencies, non-profit foundations and regional and national organizations to support cancer research are provided below for UVM Cancer Center researchers. This of funding is considered NCI approved peer-reviewed funding and can also be found in PDF format at the following link: NCI Peer-Reviewed Fund Sources


  1. Agency for Healthcare Research and Quality (AHRQ)
  2. Alex’s Lemonade Stand Foundation (ALSF)
  3. American Association of Cancer Research (AACR)
  4. American Cancer Society (ACS) (national office only)
  5. American Foundation for AIDS Research (amfAR)
  6. American Institute for Cancer Research (AICR)
  7. California Institute for Regenerative Medicine (CIRM)
  8. Cancer Prevention Research Institute of Texas (CPRIT)
  9. Center for Disease Control and Prevention (CDC)
  10. Central Office of the Veterans Administration (VA) (excluding local/regional & “block” grants)
  11. Environmental Protection Agency (EPA)
  12. The Flight Attendant Medical Research Institute (FAMRI)
  13. Florida Biomedical Research Program (FBRP)
  14. Food and Drug Administration (FDA)
  15. Howard Hughes Medical Institute (HHMI)
  16. Leukemia and Lymphoma Society (LLS)
  17. Melanoma Research Alliance (MRA)
  18. Multiple Myeloma Research Foundation (MMRF)
  19. National Institute for Occupational Safety and Health (NIOSH)
  20. National Science Foundation (NSF)
  21. New York State Department of Health Wadsworth Center/New York State Stem Cell Science Program (NYSTEM)
  22. Patient-Centered Outcomes Research Institute (PCORI)
  23. Prevent Cancer Foundation (PCF)
  24. Prostate Cancer Foundation (PCF)
  25. Susan G. Komen for the Cure
  26. The California Breast Cancer Research Program (CBCRP)
  27. The California Tobacco Related Disease Research Program (TRDRP)
  28. U.S. Army (DOD) special research programs *

Highlights: New & Updated

New and Updated
New VT Dept. of Health Cancer Plan Implementation Grant Funding; $15,000 to $35,000 requests considered. The intent of the Request for Proposals (RFP) is to fund projects
that are directly linked to preventing, detecting and treating cancer, as well as improving the lives of cancer survivors and their families. Applications due December 19, 2017 by 4 PM
New Neuroendocrine Tumor Research Foundation-AACR Grant;  $250,000 over two years. "This grant is available to independent junior and senior investigators to develop and study new ideas and innovative approaches that have direct application and relevance to neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, or clinical cancer research." Applications due January 9, 2019 by 1 PM
New UVM Vice President for Research announces a Call for Proposals for the 2018 round of SPARK VT, a program designed to assist faculty members in translating innovative discoveries into the marketplace by supporting pilot projects. The deadline for this year’s competition is January 26, 2018.
New National Cancer Institute(NCI)/NIH/DHHS – Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): RFA-CA-17-038 (UG3/UH3) AND RFA-CA-17-039 Coordinating Center (U24) support research to establish an evidence base for multilevel interventions that increase rates of colorectal cancer (CRC) screening, follow-up, and referral-to-care, and best practices for how multilevel interventions can be scaled-up to reduce the burden of CRC on the United States (U.S.) population. Applications for both the UG3/UH3 and the U24 are due January 18, 2018, by 5:00 PM local time. These programs expire January 19, 2018.
New National Cancer Institute(NCI)/NIH/DHHS – Cancer Moonshotâ„  Funding Opportunities 17 new funding opportunities Application due dates vary by program.
New The Mary Kay Foundation has invited one proposal from the University of Vermont for a two-year, $100,000 research grant in support of translational research in ovarian, uterine, breast or cervical cancer. This is a Limited Competition, with only one candidate from UVM allowed. Please contact edward.north@uvm.edu by December 12, 2017 if you wish to apply.
Updated American Association for Cancer Research (AACR) - Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award provides $50,000 over one year to promising investigators to encourage and promote quality research in clinical oncology. Application deadline is December 12, 2017.
Updated American Association for Cancer Research (AACR) - Conquer Cancer Foundation of ASCO Clinical and Translational Cancer Research Fellowships provides $50,000 over one year to promising investigators to encourage and promote quality research in clinical oncology. Application deadline is December 12, 2017.
New American Association for Cancer Research (AACR) Triple Negative Breast Cancer Foundation Research Fellowship provides a three-year grant of $165,000 to support the salary and benefits of the fellow while working on mentored triple negative breast cancer research. Application deadline is December 13, 2017.
Updated Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF) - Epidemiology Grants are two-year awards for up to $100,000 per year that are designed to support hypothesis-driven research that focuses on the epidemiology, early detection and prevention of childhood cancer or comparative effectiveness and outcomes research related to detection, prevention and treatment. Applications are due December 15, 2017.
New Department of Defense (DOD)-U.S. Army Medical Research and Materiel Command (USAMRMC)-Office of Congressionally Directed Medical Research Programs (CDMRP) announces FY17 Kidney Cancer Research Program (KCRP) funding opportunities with mandatory pre-application deadlines of 5:00 p.m. Eastern time (ET), December 20, 2017.
New National Cancer Institute(NCI)/NIH/DHHS - Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival - PAR-18-006 (Reissue of PAR 16-122 R01 Clinical Trial Optional) AND AND PAR-18-016 (Reissue of PAR-16-123 R21 Clinical Trial Optional) invite applications for transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Application deadline for R01 is January 6, 2018 and for R21 deadline is January 16, 2018
New National Cancer Institute(NCI)/NIH/DHHS - Improving Outcomes in Cancer Treatment-Related Cardiotoxicity: PA-18-003 (reissue of 116-035 R01 Clinical Trial Optional) AND PA-18-013 (R21 Clinical Trial Optional) encourage collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. Application deadline for R01 is January 6, 2018 and for R21 deadline is January 16, 2018 after which standard dates apply for both. These programs expire January 8, 2019.
Updated American Gastroenterological Association (AGA) Caroline Craig Augustyn and Damian Augustyn Award in Digestive Cancer supports young investigators, instructors, research associates or equivalents conducting research relevant to the pathogenesis, prevention, diagnosis, or treatment of digestive cancer with a one-time $40,000 award. Applications are due January 12, 2018.
New Pancreatic Cancer Action Network - Translational Research Grant provides $500,000 over two years, with the potential to expand to a third year with additional funds, to support high priority pancreatic cancer research that is poised for important translational next steps to help move scientific discovery to application in patients. Applications are due January 15, 2018.
New American Society of Hematology - (ASH) Research Training Award for Fellows (RTAF) - Junior & Senior Investigator Awards provide an opportunity for first-, second-, and third-year medical students to gain experience in hematology research under the mentorship of an ASH member and to learn more about the specialty. Applications are due January 15, 2018.
New National Cancer Institute(NCI)/NIH/DHHS - NCI Research Specialist Award -Laboratory-based Scientist: PAR-18-341 (R50) AND PAR-18-342 Core-based Scientist (R50) are designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators. Applications are due January 17, 2018, by 5:00 PM local time.
New National Cancer Institute(NCI)/NIH/DHHS – Program Project Applications PAR-18-290 (Reissue of PAR 16-457 P01 Clinical Trial Optional) supports investigator-initiated Program Project (P01) applications. Applications are due January 17, 2018 January 25, 2018 after which standard dates apply for both. This program expires January 8, 2020.
New National Cancer Institute(NCI)/NIH/DHHS – Assay Validation of High Quality Markers for Clinical Studies in Cancer: PAR-18-310 (reissue of PAR-15-096 UH3 Clinical Trials Not Allowed) AND PAR-18-317 (reissue of PAR-15-095 UH2/UH3 Clinical Trial Not Allowed) support the validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. Applications for both are due February 14, 2018; July 10, 2018; October 8, 2018; February 13, 2019; July 10, 2019; October 8, 2019; February 13, 2020; July 10, 2020; October 8, 2020, by 5:00 PM local time. These programs expire October 9, 2020.
New Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF) Pediatric Oncology Student Training (POST) provides an opportunity for students to train with a mentor who is conducting research in the field of pediatric oncology during the summer break. Applications are due April 1, 2018 (11:59 PM ET).